These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30784073)

  • 1. Transfusion of HIV-infected blood products despite highly sensitive nucleic acid testing.
    Cappy P; Barlet V; Lucas Q; Tinard X; Pillonel J; Gross S; Tiberghien P; Laperche S
    Transfusion; 2019 Jun; 59(6):2046-2053. PubMed ID: 30784073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of routine HIV-1 tests in a case involving transmission with preseroconversion blood components during the infectious window period.
    Ling AE; Robbins KE; Brown TM; Dunmire V; Thoe SY; Wong SY; Leo YS; Teo D; Gallarda J; Phelps B; Chamberland ME; Busch MP; Folks TM; Kalish ML
    JAMA; 2000 Jul; 284(2):210-4. PubMed ID: 10889595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First report of human immunodeficiency virus transmission via an RNA-screened blood donation.
    Delwart EL; Kalmin ND; Jones TS; Ladd DJ; Foley B; Tobler LH; Tsui RC; Busch MP
    Vox Sang; 2004 Apr; 86(3):171-7. PubMed ID: 15078251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load.
    Katsoulidou A; Moschidis Z; Sypsa V; Chini M; Papatheodoridis GV; Tassopoulos NC; Mimidis K; Karafoulidou A; Hatzakis A
    Vox Sang; 2007 Jan; 92(1):8-14. PubMed ID: 17181585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of triplex nucleic acid test assays in United States blood donors.
    Stramer SL; Krysztof DE; Brodsky JP; Fickett TA; Reynolds B; Dodd RY; Kleinman SH
    Transfusion; 2013 Oct; 53(10 Pt 2):2525-37. PubMed ID: 23550838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First transmission of human immunodeficiency virus Type 1 by a cellular blood product after mandatory nucleic acid screening in Germany.
    Schmidt M; Korn K; Nübling CM; Chudy M; Kress J; Horst HA; Geusendam G; Hennig H; Sireis W; Rabenau HF; Doerr HW; Berger A; Hourfar MK; Gubbe K; Karl A; Fickenscher H; Tischer BK; Babiel R; Seifried E; Gürtler L
    Transfusion; 2009 Sep; 49(9):1836-44. PubMed ID: 19453990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of human immunodeficiency virus assays in window phase and elite controller samples: viral load distribution and implications for transmission risk.
    Vermeulen M; Coleman C; Mitchel J; Reddy R; van Drimmelen H; Fickett T; Busch M; Lelie N
    Transfusion; 2013 Oct; 53(10 Pt 2):2384-98. PubMed ID: 23445273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How safe is safe: new human immunodeficiency virus Type 1 variants missed by nucleic acid testing.
    Müller B; Nübling CM; Kress J; Roth WK; De Zolt S; Pichl L
    Transfusion; 2013 Oct; 53(10 Pt 2):2422-30. PubMed ID: 23782012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human immunodeficiency virus-1 and hepatitis C virus RNA among South African blood donors: estimation of residual transfusion risk and yield of nucleic acid testing.
    Fang CT; Field SP; Busch MP; Heyns Adu P
    Vox Sang; 2003 Jul; 85(1):9-19. PubMed ID: 12823725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
    Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
    Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan.
    Mine H; Emura H; Miyamoto M; Tomono T; Minegishi K; Murokawa H; Yamanaka R; Yoshikawa A; Nishioka K;
    J Virol Methods; 2003 Sep; 112(1-2):145-51. PubMed ID: 12951223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of HCV and HIV-1 antibody negative infections in Scottish and Northern Ireland blood donations by nucleic acid amplification testing.
    Jarvis LM; Dow BC; Cleland A; Davidson F; Lycett C; Morris K; Webb B; Jordan A; Petrik J
    Vox Sang; 2005 Oct; 89(3):128-34. PubMed ID: 16146504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmission of human immunodeficiency virus Type-1 by fresh-frozen plasma treated with methylene blue and light.
    Álvarez M; Luis-Hidalgo M; Bracho MA; Blanquer A; Larrea L; Villalba J; Puig N; Planelles D; Montoro J; González-Candelas F; Roig R
    Transfusion; 2016 Apr; 56(4):831-6. PubMed ID: 26585542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of human immunodeficiency virus RNA and antibody in first-time, lapsed, and repeat blood donations across five international regions and relative efficacy of alternative screening scenarios.
    Bruhn R; Lelie N; Custer B; Busch M; Kleinman S;
    Transfusion; 2013 Oct; 53(10 Pt 2):2399-412. PubMed ID: 23782054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of the risk of transfusion-transmitted viral infection by nucleic acid amplification testing in the Western Cape of South Africa: a 5-year review.
    Cable R; Lelie N; Bird A
    Vox Sang; 2013 Feb; 104(2):93-9. PubMed ID: 22924987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing.
    Stramer SL; Glynn SA; Kleinman SH; Strong DM; Caglioti S; Wright DJ; Dodd RY; Busch MP;
    N Engl J Med; 2004 Aug; 351(8):760-8. PubMed ID: 15317889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nationwide nucleic acid amplification testing of hepatitis B virus, hepatitis C virus and human immunodeficiency virus type 1 for blood transfusion and follow-up study of nucleic acid amplification positive donors.
    Japanese Red Cross NAT Screening Research Group
    Jpn J Infect Dis; 2000 Jun; 53(3):116-23. PubMed ID: 10957709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Routine screening of blood donations at Qingdao central blood bank, China, for hepatitis B virus (HBV) DNA with a real-time, multiplex nucleic acid test for HBV, hepatitis C virus, and human immunodeficiency virus Types 1 and 2.
    Yang Z; Xu L; Liu L; Feng Q; Zhang L; Ma W; Saldanha J; Wang M; Zhao L
    Transfusion; 2013 Oct; 53(10 Pt 2):2538-44. PubMed ID: 23480568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of HIV transfusion transmission risk in South Africa: a 10-year analysis following implementation of individual donation nucleic acid amplification technology testing and donor demographics eligibility changes.
    Vermeulen M; Lelie N; Coleman C; Sykes W; Jacobs G; Swanevelder R; Busch M; van Zyl G; Grebe E; Welte A; Reddy R
    Transfusion; 2019 Jan; 59(1):267-276. PubMed ID: 30265757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood screening nucleic acid amplification tests for human immunodeficiency virus Type 1 may require two different amplification targets.
    Chudy M; Weber-Schehl M; Pichl L; Jork C; Kress J; Heiden M; Funk MB; Nübling CM
    Transfusion; 2012 Feb; 52(2):431-9. PubMed ID: 21810100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.